Avanos Medical (AVNS) Change in Cash (2013 - 2026)

Avanos Medical (AVNS) has 14 years of Change in Cash data on file, last reported at -$24.2 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash fell 126.17% year-over-year to -$24.2 million; the trailing twelve-month figure through Mar 2026 stood at -$31.4 million (down 248.11% YoY), and the FY2025 full-year result was -$17.9 million, down 189.5% from the prior year.
• Change in Cash retreated to -$24.2 million in Q1 2026, from $19.3 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $25.3 million in Q3 2023 to a low of -$32.0 million in Q1 2023.
• A 5-year average of -$3.1 million and a median of -$6.7 million in 2025 frame the typical range for Change in Cash.
• Across the five-year window, Change in Cash soared 1200.0% in 2022 and sank 731.82% in 2023, its largest moves.
• Tracing AVNS's Change in Cash over 5 years: stood at $10.7 million in 2022, then sank by 281.31% to -$19.4 million in 2023, then soared by 196.39% to $18.7 million in 2024, then rose by 3.21% to $19.3 million in 2025, then plunged by 225.39% to -$24.2 million in 2026.
• Business Quant data shows AVNS's Change in Cash at -$24.2 million in Q1 2026, $19.3 million in Q4 2025, and -$19.8 million in Q3 2025.